A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
The use of force on a prisoner at Strangeways did contribute to his death, an inquest heard.
A four-year-old girl died in her mother's arms days after she was mown down in a suspected hit-and-run in St Helens.
Police are searching land on the Wirral after claims a man who has been missing for more than 20 years may have been killed and buried.